In the present study, we recruited 360 NSCLC patients and 360 cancer-free control, aim to investigate whether OPN-66 T/G, -156G/GG, and -443C/T genotypes affect the survival of patients; meanwhile to determine whether they have an association with incidence of bone metastasis development. Here, SPP1 is linked to cancer.